Australian health insurer Medibank has introduced a new benefit for eligible members to support pharmacogenetic (PGx) testing, marking a move toward personalised healthcare through genetic insights.
The initiative allows selected extras policyholders to access funding for DNA-based testing used to assess individual responses to medications.
Pharmacogenetic testing helps medical professionals determine how patients metabolise drugs based on their genetic profile.
This approach may reduce the risks associated with trial-and-error prescribing, particularly in treatment areas such as mental health, cancer, cardiovascular conditions, and neurological disorders.
Dr Andrew Wilson, Medibank’s chief medical officer and a practising psychiatrist, noted that the integration of PGx testing into health insurance products reflects a broader emphasis on data-informed clinical decisions.
“PGx testing is a great example of using technology to improve patient care. It allows health professionals to make data-driven decisions about which medications are most likely to work for each patient, based on their unique genetic profile,” he said.
He added that variability in drug responses among patients has long been a challenge.
“For people who need treatment for mental health conditions, finding the right drug may take a fair bit of trial and error – sometimes months or years of it. In some cases, the medication that has been prescribed is not effective and the patient’s condition has not improved,” Wilson said.
According to Medibank, PGx benefits are available immediately for eligible members on selected Extras products, with no waiting period required.
In a separate development, Medibank has also launched a mental health initiative in partnership with comedian and actor Magda Szubanski.
The campaign introduces a conversation-focused card game, “The Medibank Family Roast,” designed to promote open discussions about mental health within families and social circles.
The campaign launch coincides with Szubanski’s public disclosure of her diagnosis with Stage 4 Mantle Cell Lymphoma. Despite this, she has continued her work on the campaign, including helping to develop fictional elements of her well-known television character Sharon Strzelecki.
Szubanski said this project Australians a simple way to engage in conversations that might otherwise be difficult.
“Supporting the mental well-being of Australians has always been close to my heart – whether through making people laugh or through raising awareness and funds for trauma,” she said.
The campaign is part of a broader $50 million investment by Medibank into mental health programs over five years. It was developed in collaboration with mental health experts and a team of creative and media agencies, including Colenso BBDO and Carat Melbourne.
A 60-second television advertisement featuring Strzelecki and her fictional children aired on June 8 to launch the campaign nationally.
